In recent years, England has tackled a significant global health issue: the mpox outbreak, primarily affecting gay and bisexual men who have sex with men (GBMSM). While initial efforts to curb the crisis within England saw success through behavior modification and targeted vaccination, the disease continues to pose a threat globally, with Africa seeing an expanding outbreak. English public health policy is now focusing on devising economical and effective vaccination strategies to thwart future outbreaks. Recent studies present a compelling case for a dual approach combining pre-emptive and reactive vaccinations. This tactical move is not only anticipated to minimize outbreak risk but also to optimize costs over a decade-long horizon.
Methodology and Analytical Approach
Researchers employed a sophisticated mathematical model to predict mpox transmission rates among high-risk GBMSM populations. The study analyzed the cost associated with various vaccination strategies and their effectiveness over a 10-year period. Factors such as vaccine costs, case management, and public health responses during an outbreak were considered, alongside projected vaccine efficacy of 78% or 89% contingent on receiving one or two doses, respectively.
Findings Highlight Optimal Strategies
All tested vaccination strategies yielded positive outcomes in reducing future mpox outbreaks, gaining quality-adjusted life years (QALYs), and lowering overall costs compared to forgoing vaccination. The combination of continuous pre-emptive vaccination (54 doses daily) with additional reactive vaccination (81 doses daily) during outbreaks emerged as the most cost-effective strategy. This approach is projected to save approximately A8.8 million while adding 108.6 QALYs over the next decade. Moreover, pre-emptive vaccination remains robustly favorable even when factoring in price fluctuations and various sensitivity analyses.
Key takeaways include:
– A strategic mix of pre-emptive and reactive vaccinations offers superior cost savings.
– Vaccine costs influence strategy preference, with any cost over A330/dose challenging viability.
– Sole reliance on reactive vaccination is viable only when external response costs are ignored.
Preventative measures, especially pre-emptive vaccination, are undeniably valuable in the fight against mpox. Continual investment in vaccination, complemented by strategic reactive doses during active outbreaks, has demonstrated both health and economic benefits.
To maintain momentum, policymakers should ensure vaccines remain affordable, ideally under A330 per dose. Additionally, ongoing analysis and adaptability will be crucial to refine approaches as more data become available. The demonstrated success of this strategy not only offers a blueprint for other regions grappling with mpox but reinforces the importance of proactive and reactive synergy in public health planning.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
